Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q3 · 1,8 19 matched articles SCIE

Journal detail

Melanoma Research

Publisher
Lippincott Williams and Wilkins
Country
United States · Northern America
Type
journal
ISSN
  • 09608931
  • 14735636
Scopus 0,74 SJR
Scopus Q2 SJR Q
WoS Q3 JCR Q
WoS 1,8 JIF
Scopus 86 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,74
  • Quartile Q2
  • H-Index 86
  • Cites/doc 1,73
  • Docs (3y) 217
  • Cites (3y) 371

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q3
  • JIF 1,8
  • 5Y JIF 1,7
  • JCI 0,52

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Cancer Research Q3
  • Dermatology Q2
  • Oncology Q2

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

WoS categories

  • Oncology | Dermatology | Medicine, Research & Experimental

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q3 0,74 1,8 1,7 0,52 Q3 86
2024 Q2 Q3 0,657 1,9 2 0,5 Q3 82
2023 Q2 Q3 0,633 1,5 1,9 0,55 Q3 82
2022 Q1 Q3 0,74 2,2 2,6 0,68 Q2 82
2021 Q1 Q2 0,829 3,2 3 0,81 Q2 82
2020 Q1 Q2 1,072 3,6 3,4 0,94 Q2 82
2019 Q1 Q2 0,854 2,8 2,4 0,89 Q2 82
2018 — Q2 — 2,4 2,3 1 Q2 —
2017 Q1 Q1 1,259 3,1 2,8 1,04 Q2 82
2016 Q1 Q2 1,035 2,6 2,4 — — 82
2015 Q1 Q2 1,165 2,2 2,2 — — 82
2014 Q1 Q2 1,032 2,3 2,1 — — 82
2013 Q1 Q2 1,113 2,1 2,2 — — 82
2012 Q1 Q1 1,154 2,5 2,3 — — 82
2011 Q1 Q2 0,998 2,2 2,3 — — 82
2010 Q1 Q2 0,998 2,3 2,3 — — 82
2009 — Q2 — 2,1 2,2 — — —
2008 — Q2 — 2,3 2,1 — — —
2007 — Q1 — 2,2 2,1 — — —
2006 — Q2 — 1,7 — — — —
2005 — Q2 — 1,5 — — — —
2004 — Q1 — 1,7 — — — —
2003 — Q1 — 2,2 — — — —
2002 — Q1 — 1,8 — — — —
2001 — Q1 — 1,9 — — — —
2000 — Q1 — 1,9 — — — —
1999 — Q2 — 1,4 — — — —
1998 — Q1 — 1,5 — — — —
1997 — Q1 — 1,6 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 DERMATOLOGY SCIE Q3 Q3 61/99
2025 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q3 136/191
2025 ONCOLOGY SCIE Q4 Q3 264/333
2024 DERMATOLOGY SCIE Q3 Q3 53/96
2024 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q3 132/195
2024 ONCOLOGY SCIE Q3 Q3 243/328
2023 DERMATOLOGY SCIE Q3 Q3 59/94
2023 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q3 140/189
2023 ONCOLOGY SCIE Q4 Q3 259/322
2022 DERMATOLOGY SCIE Q3 Q2 44/70
2022 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 Q2 106/136
2022 ONCOLOGY SCIE Q4 Q2 200/241
2021 DERMATOLOGY SCIE Q2 Q2 28/69
2021 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q2 95/139
2021 ONCOLOGY SCIE Q3 Q2 172/245
2020 DERMATOLOGY SCIE Q2 Q2 21/69
2020 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q2 78/140
2020 ONCOLOGY SCIE Q3 Q2 148/242
2019 DERMATOLOGY SCIE Q2 Q2 25/68
2019 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q2 75/139
2019 ONCOLOGY SCIE Q3 Q2 155/244
2018 DERMATOLOGY SCIE Q2 Q2 27/66
2018 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q2 75/136
2018 ONCOLOGY SCIE Q3 Q2 160/230
2017 DERMATOLOGY SCIE Q1 Q2 11/64
2017 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q2 56/133
2017 ONCOLOGY SCIE Q3 Q2 116/223
2016 DERMATOLOGY SCIE Q2 — 16/63
2016 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 60/128
2016 ONCOLOGY SCIE Q3 — 127/217
2015 DERMATOLOGY SCIE Q2 — 19/61
2015 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 68/124
2015 ONCOLOGY SCIE Q3 — 142/213
2014 DERMATOLOGY SCIE Q2 — 16/63
2014 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 65/123
2014 ONCOLOGY SCIE Q3 — 140/211
2013 DERMATOLOGY SCIE Q2 — 17/61
2013 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 67/124
2013 ONCOLOGY SCIE Q3 — 132/203
2012 DERMATOLOGY SCIE Q1 — 14/59
2012 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 56/121
2012 ONCOLOGY SCIE Q3 — 102/197
2011 DERMATOLOGY SCIE Q2 — 19/58
2011 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 57/112
2011 ONCOLOGY SCIE Q3 — 114/196
2010 DERMATOLOGY SCIE Q2 — 17/55
2010 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 46/106
2010 ONCOLOGY SCIE Q3 — 108/185
2009 DERMATOLOGY SCIE Q2 — 18/48
2009 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 45/93
2009 ONCOLOGY SCIE Q3 — 102/166
2008 DERMATOLOGY SCIE Q2 — 12/43
2008 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 37/83
2008 ONCOLOGY SCIE Q3 — 84/143
2007 DERMATOLOGY SCIE Q1 — 10/41
2007 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 34/81
2007 ONCOLOGY SCIE Q3 — 81/132
2006 DERMATOLOGY SCIE Q2 — 15/39
2006 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 41/76
2006 ONCOLOGY SCIE Q3 — 93/127
2005 DERMATOLOGY SCIE Q2 — 15/39
2005 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 45/72
2005 ONCOLOGY SCIE Q4 — 94/123
2004 DERMATOLOGY SCIE Q1 — 7/38
2004 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 35/71
2004 ONCOLOGY SCIE Q3 — 82/123
2003 DERMATOLOGY SCIE Q1 — 6/38
2003 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 26/72
2003 ONCOLOGY SCIE Q2 — 58/120
2002 DERMATOLOGY & VENEREAL DISEASES SCIE Q1 — 8/40
2002 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 34/74
2002 ONCOLOGY SCIE Q3 — 65/114
2001 DERMATOLOGY & VENEREAL DISEASES SCIE Q1 — 9/38
2001 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 27/75
2001 ONCOLOGY SCIE Q2 — 53/107
2000 DERMATOLOGY & VENEREAL DISEASES SCIE Q1 — 8/36
2000 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 29/74
2000 ONCOLOGY SCIE Q2 — 45/103
1999 DERMATOLOGY & VENEREAL DISEASES SCIE Q2 — 10/36
1999 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 32/76
1999 ONCOLOGY SCIE Q3 — 59/105
1998 DERMATOLOGY & VENEREAL DISEASES SCIE Q1 — 7/35
1998 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 26/72
1998 ONCOLOGY SCIE Q2 — 52/104
1997 DERMATOLOGY & VENEREAL DISEASES SCIE Q1 — 6/32
1997 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 23/61
1997 ONCOLOGY SCIE Q2 — 38/102